Predicting Cyclosporine-Related Liver Injury in Pediatric Thalassemia after Hematopoietic Stem Cell Transplantation

Fuli Qin, Jiu’an Lan, Jun Luo, Shuangyi TangAuthorea 2025 · DOI

Abstract

Children with thalassemia often need a stem cell transplant, and cyclosporine is commonly used afterward to prevent transplant rejection. Although effective, cyclosporine can sometimes harm the liver, which may lead to serious health issues if not identified early. In this study, we analyzed clinical information from children who received cyclosporine after transplantation to find factors that might predict liver injury. We found that certain laboratory tests and cyclosporine blood levels were helpful in determining which children were at higher risk. Using these factors, we built a prediction model that accurately identified patients likely to develop liver injury. This tool can help doctors adjust cyclosporine doses sooner and monitor high-risk patients more closely. Our results support safer and more personalized cyclosporine use in children undergoing stem cell transplantation.
BibTeX
@misc{qin2025predicting,
  author = {Fuli Qin and Jiu’an Lan and Jun Luo and Shuangyi Tang},
  title = {{Predicting Cyclosporine-Related Liver Injury in Pediatric Thalassemia after Hematopoietic Stem Cell Transplantation}},
  year = {2025},
  doi = {10.22541/au.176485154.46953464/v1},
  howpublished = {Authorea},
}

Loading related content...

Figure